RECRUITINGINTERVENTIONAL
Adverse Outcomes and Mortality in Liver Transplant
About This Trial
Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
Who May Be Eligible (Plain English)
Who May Qualify:
1. All patients with end-stage liver disease undergoing evaluation for liver transplantation
2. Patient clinically indicated for MRI during transplant candidacy evaluation
3. Adult
Who Should NOT Join This Trial:
1\. Contra indication to MRI
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. All patients with end-stage liver disease undergoing evaluation for liver transplantation
2. Patient clinically indicated for MRI during transplant candidacy evaluation
3. Adult
Exclusion Criteria:
1\. Contra indication to MRI
Treatments Being Tested
DIAGNOSTIC_TEST
MAsS
Add MAsS to standard of care MRI scan
Locations (1)
Mayo Clinic Arizona
Phoenix, Arizona, United States